Covered recipient · General Payments record
JENNY MINTON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2025
$6,223.32
- Reported across 299 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $220.67 | 11 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $53.75 | 3 |
| Astellas Pharma US Inc | $43.64 | 2 |
| GlaxoSmithKline, LLC. | $23.71 | 1 |
| Exact Sciences Corporation | $22.71 | 1 |
| Acerta Pharma LLC | $21.75 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.33 | 1 |
| ABBVIE INC. | $18.64 | 1 |
| Daiichi Sankyo Inc. | $17.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.64 | 08/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204969963 | CMS |
| Astellas Pharma US Inc | $17.76 | 02/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238740296 | CMS |
| Astellas Pharma US Inc | $25.88 | 03/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238766402 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.75 | 07/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206322583 | CMS |
| Daiichi Sankyo Inc. | $17.14 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1197060931 | CMS |
| Exact Sciences Corporation | $22.71 | 05/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235498254 | CMS |
| GlaxoSmithKline, LLC. | $23.71 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190408797 | CMS |
| Novo Nordisk Inc | $17.69 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188808586 | CMS |
| Novo Nordisk Inc | $20.77 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188708478 | CMS |
| Novo Nordisk Inc | $15.29 | 10/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188779696 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.33 | 10/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224011723 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.